• Winning FDA approval for a new drug or medical treatment requires extensive--and expensive--human trials for safety and effectiveness. Costs vary widely, depending largely on the conditions being treated and the number of subjects required. Roughly 50 stem-cell cardiac therapies are currently in trials in the United States. Among them are these two, both designed for "no hope" populations, meaning that relatively few participants are required--perhaps 100 to 300.

    Read More »